As of 2026-06-07, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 11.8x | 6.9x |
| Forward P/E multiples | 9.0x - 13.7x | 12.2x |
| Fair Price | (10.76) - (12.90) | (11.18) |
| Upside | -582.6% - -678.4% | -601.2% |
| Date | EV/EBITDA |